Interim Director
Jamie Renbarger, MD, came to IU School of Medicine from Baylor College of Medicine, where she completed her pediatric hematology/oncology fellowship training and initiated her clinical pharmacology research at the Texas Children’s Cancer Center. An associate professor of pediatrics, Renbarger is interested in the pharmacogenetics of the vinca alkaloids in treatment of pediatric and adult malignancies. In addition, she and David M. Haas, MD, have developed PREGMED, a collaborative research group focusing on maternal-fetal pharmacology and pharmacogenetics with multiple active research projects.
